Immunotherapy has the potential to treat almost any type of cancer. Learn how we are making this a reality for more patients sooner.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
Have a creative idea for a fundraiser you'd like to host to benefit cancer research? Or are you seeking ideas for how you can help us achieve our mission to conquer all cancers? Get inspired by our ideas and tips.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Numerous challenges can derail progress in finding new immune-based cancer treatments. We're solving some of the biggest challenges, keeping promising new immunotherapies on the fast track to patients.
Cancer patients are now beginning to benefit from advances in cancer immunotherapy. Watch this story of hope and survival, and be inspired to help us conquer cancer.
Browse our directory of scientific leaders who volunteer their time and expertise to help ensure that we fund the most innovative and promising research possible.
Immune-based cancer treatments are here, and CRI has been behind this new class of cancer therapies from the beginning.
Together we can find therapies to prevent, treat, and - one day - cure cancer.
From brain cancer to melanoma, we've seen a number of major treatment breakthroughs for many different types of cancer. See how the Cancer Research Institute has been making this a reality for more patients from the very beginning.
In honor of colorectal cancer awareness month, a look back at our understanding of the role of bacteria in cancer.
Dr. Lawrence Fong will discuss latest breakthroughs in this free March 18th webinar on colorectal cancer.
1,050+ Cancer immunotherapy clinical trials now enrolling patients
3,000 scientists & clinicians supported around the world with CRI funding
120 new treatments tested in cancer patients in CRI clinical trials
85% of donations go directly to programs